AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 81 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,847,587 | +39.8% | 4,101,193 | -10.0% | 0.18% | +77.2% |
Q1 2023 | $1,321,823 | -36.3% | 4,558,012 | -1.2% | 0.10% | -24.6% |
Q4 2022 | $2,074,625 | +6.3% | 4,611,302 | +24.3% | 0.13% | +6.3% |
Q3 2022 | $1,952,000 | -0.3% | 3,710,778 | -4.3% | 0.13% | +28.6% |
Q2 2022 | $1,958,000 | -73.4% | 3,877,311 | +21.1% | 0.10% | -69.9% |
Q1 2022 | $7,361,000 | -44.9% | 3,200,593 | +13.8% | 0.33% | -30.6% |
Q4 2021 | $13,364,000 | +10.8% | 2,813,560 | +85.5% | 0.47% | +23.7% |
Q3 2021 | $12,060,000 | +3.3% | 1,516,955 | -9.5% | 0.38% | +14.5% |
Q2 2021 | $11,672,000 | -13.9% | 1,677,036 | -2.0% | 0.33% | -16.2% |
Q1 2021 | $13,560,000 | -12.7% | 1,712,088 | -13.3% | 0.40% | -17.7% |
Q4 2020 | $15,538,000 | -29.8% | 1,974,302 | -36.8% | 0.48% | -29.0% |
Q3 2020 | $22,145,000 | -25.3% | 3,123,430 | -2.5% | 0.68% | -24.3% |
Q2 2020 | $29,645,000 | +126.2% | 3,204,830 | +12.4% | 0.89% | +82.1% |
Q1 2020 | $13,106,000 | -39.9% | 2,852,260 | 0.0% | 0.49% | -26.8% |
Q4 2019 | $21,791,000 | -0.7% | 2,852,260 | 0.0% | 0.67% | -17.5% |
Q3 2019 | $21,934,000 | +12.3% | 2,852,260 | 0.0% | 0.81% | +35.0% |
Q2 2019 | $19,538,000 | -8.5% | 2,852,260 | +7.5% | 0.60% | -9.6% |
Q1 2019 | $21,351,000 | +12.8% | 2,652,260 | +4.9% | 0.67% | +14.4% |
Q4 2018 | $18,929,000 | -21.7% | 2,527,260 | 0.0% | 0.58% | -10.6% |
Q3 2018 | $24,186,000 | +3.3% | 2,527,260 | +14.2% | 0.65% | -31.3% |
Q2 2018 | $23,414,000 | +28.0% | 2,213,052 | +20.0% | 0.95% | +14.9% |
Q1 2018 | $18,299,000 | +83.4% | 1,844,673 | 0.0% | 0.82% | +85.8% |
Q4 2017 | $9,980,000 | +26.3% | 1,844,673 | +15.1% | 0.44% | +14.7% |
Q3 2017 | $7,902,000 | +28.8% | 1,602,903 | +0.6% | 0.39% | -20.5% |
Q2 2017 | $6,133,000 | – | 1,592,903 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $532,000 | 6.17% |
Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |